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ABSTRACT
Objective: The objective of the present work was to develop an in situ gel composed of Pluronic F-127, Carbopol 934, and methylparaben and loaded 
with fluconazole using DoE software to sustain the delivery of drug in the buccal cavity.
Methods: In situ gels were prepared by temperature-induced method, by employing DoE and characterized by Fourier transform infrared (FTIR), 
differential scanning calorimeter (DSC), and evaluated for gelation temperature, gelation time, adhesive force, and in vitro diffusion studies.
Results: Both FTIR and DSC studies suggested that there were no chemical interactions present between both drug and polymers. The formulated gels 
S1, S3, and S9 showed gelation at a body temperature. The viscosity, gel strength, and mucoadhesive force for the formulated in situ gels were found 
to be within the ranges of 375–738 cps, 35–62 s, and 4650–5210.32 dynes/cm2, respectively. The in vitro diffusion studies indicated that optimized 
in situ gel S3 exhibited the improved ability to sustain the drug compared to other formulations.
Conclusion: Thus, developed in situ gel system was determined to be effective in terms of eradication of oral thrush.
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INTRODUCTION
Oral thrush is defined as a yeast or fungal infection caused by Candida 
albicans, generally observed in oral cavities of babies and elderly people 
with dentures [1]. These fungal organisms are present in oral cavity 
within a wide range of population; changes in the environment of oral 
cavity lead to these fungal infections, other factors that trigger these 
fungal infections are hyposalivation, usage of immune suppressants, and 
radiation therapy to cure diseases [2]. To treat these fungal infections, 
conventional formulations such as gels, torches, creams, mouth paints, 
rinses, and suspensions are used to deliver the drug locally into the 
oral cavity. These formulations are also used to treat various conditions 
such as bacterial infections, fungal infections, periodontal disease, 
toothache, and dental caries [3].
Degradation of drugs in the oral cavity salivary fluid causes incomplete 
eradication of candidiasis. The delivery of drugs locally in the oral 
cavity will result in improved efficacy to eliminate the infection. The 
antifungal drugs with enhanced stability and more residence time 
will permit to penetrate through the tissue membrane of buccal cavity 
to act on Candida species for extended period [4,5]. To deliver the 
drug locally in the buccal cavity in this research work, in situ gel was 
selected as vehicle to deliver the drug due to its various advantages 
such as reduced dose frequency, and enhanced patient comfort and 
compliance [6,7].
Fluconazole is a wide-spectrum antifungal drug belonging to the class 
of imidazole derivatives. Fluconazole shows its action by bonding 
with lanosterol 14-alpha-dimethylase and inhibits the production 
of ergosterol, in turn, leading to loss of integrity in the fungal cell 
membrane. In addition to this, it also decreases the binding of fungal 
cells to the host tissue and prohibits the multiplication and growth of 
fungi [8].
The main interest of the current study is to formulate thermoreversible 
in situ gels using Carbopol-934 and Pluronic F-127, for release of 
Fluconazole to treat candidiasis in the oral cavity. Hence, the systemic 




Fluconazole was obtained as a gift sample from Bayer Pharmaceutical 
Pvt., Ltd, Thane, India, and Pluronic F-127was obtained as a gift sample 
from Triveni Interchem Pvt., Ltd, Vapi, India.
Methods
Formulation and optimization of temperature-induced in situ gel 
loaded with fluconazole.
Experimental design
A 32 randomized full factorial design for the study of in situ gel at 
two factors and three levels. Factors included in the study Pluronic 
F-127 and Carbapol-934 are used as independent variables, whereas 
levels -1 and +1 were used as low and high, respectively. Viscosity, pH, 
and gelation time were used as dependent variables. Best fit model for 
statistical analysis was considered significant when p value was <0.05. 
Design-Expert software (DX11) State-Ease Inc., USA, was used to study 
the effect of different variables dependent on the properties of viscosity, 
pH, and gelation time [9].
Formulation of temperature-induced in situ gel loaded 
with fluconazole
Thermoreversible in situ gels were prepared using cold technique; this 
process involves slow addition of Pluronic F-127 and methylparaben 
in a sufficient quantity of cold distilled water. The required quantity 
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i8.26190
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of Carbopol 934 was taken in another beaker and allowed it to swell 
for overnight. Polymer solutions were stirred until uniform solutions 
were obtained using a magnetic stirrer (Remi, India). The mixture 
was then kept at room temperature for 24 h. To adjust the pH to 7, a 
little quantity of triethanolamine was added. Fluconazole was weighed 
and solubilized in dimethylsulfoxide by stirring continuously until a 
uniform drug solution was formed. Drug solution was incorporated 
into gel before in vitro studies [1]. The different variables and 
compositions of thermoreversible gels obtained from DoE were given 
in Tables 1 and 2.
Characterizations
Fourier transform-infrared (FTIR) studies
The nature of drug-excipient interacting forces during gelation process 
was characterized using FTIR by employing potassium bromide pellet 
method [10].
Differential scanning calorimetry
All differential scanning calorimeter (DSC) studies of pure drug and 
physical mixture were done using Shimadzu DSC-TSW 60. A few 
mg of sample were entirely sealed into aluminum crimp pan cells. 
Under nitrogen atmosphere, it was heated at constant temperature of 
10°C/min [10].
Evaluation of prepared in situ gels
Visual appearance and clarity
The formulated gels were examined for visual appearance and clarity 
by observing the formulated in situ gels against a white and black 
background to check the presence of any particulate matter [11].
pH
The most accurate common means of measuring pH are through a 
laboratory device called a probe pH meter. Measurement is made by 
submerging the probe in the liquid until a reading is registered by the 
meter [12,13].
Viscosity
Viscosity of all formulated in situ gels was done using Brookfield 
viscometer using spindle no. 6 at 30 rpm, at two different temperatures, 
namely 8±1°C and 37±1°C [12,14].
Gelation temperature and gelation time
Evaluation of gelation temperature and gelation time was done by taking 
required quantity of gelling a thin-walled test tube and places it in a 
thermostatically controlled water bath with frequent shaking until it 
got converted to gel. Complete gelation was confirmed by tilting the test 
tube upside down, where the gel does not flow out. The gel formation 
was evaluated visually and gelation time was observed [12,15].
Determination of mucoadhesive force
Mucoadhesive force can be termed as strength required to disconnect 
the formulated gel from oral mucosa. Mucoadhesive force was 
determined using modified balance technique. This method was done 
using chicken mucosa and two vials. Tissue specimen with appropriate 
thickness and surface area was taken from chicken mucosa and tied 
to each side of vial using thread and stored at 32–34°C for about 
15 min. Weighing balance was attached to one of the vials and specified 
quantity of gel was positioned between the tissue specimens attached 
to bottom of the vials. The force required to detach the gel from mucosa 
was measured [16].
In vitro diffusion studies
The in vitro diffusion study of the formulated in situ gel was performed 
by modified USP dissolution apparatus-1. A Whatman filter paper 
was taken in the basket and wetted by dipping in simulated lacrimal 
fluid for a time period of at least 1 min to ensure the contact of release 
medium with formulation. 100 µl of the formulation was applied to 
the Whatman filter paper and 50 ml of simulated lacrimal fluid was 
filled in a beaker and basket was rotated over its surface. At regular 
intervals, 3 ml samples were withdrawn replaced with an equal 
amount of fresh simulated lacrimal fluid. The samples were analyzed 
spectrophotometrically for fluconazole content using ultraviolet (UV)-




The IR spectra of pure drug Fluconazole were compared with the IR 
spectra of physical mixture. The comparison between two spectra 
Table 1: Variables in 32 factorial design of fluconazole loaded 
in situ gels
Variables Low (%) High (%)
Pluronic F-127 (X1) 12 15
Carbopol 934 (X2) 0 0.04
Table 2: 32 factorial design layout for fluconazole loaded in situ 
gels
Run Pluronic F-127 (X1)/factor 
1 (ml)











Fig. 1: Fourier transform-infrared spectra of pure drug and drug-
excipient mixture
Fig. 2: Differential scanning calorimeter of pure drug and physical 
mixture
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Fig. 3a-c: Three-dimensional response surface plot depicting the impact of factors over responses
Fig. 4a-c: Contour plot showing the impact of the impact of factors over responses
Table 3: Observed response in 32 factorial design for temperature-induced in situ gel loaded with fluconazole
Std. Run Pluronic F-127 (X1)/factor 
1 (ml)
Carbapol-934 (X2) 





Response Y3 gelation 
time (s)
6 1 15 0.02 4.7 44.8 36
3 2 15 0 4.8 42.1 44
9 3 15 0.04 4.9 43.3 35
2 4 13.5 0 4.6 39.09 37
8 5 13.5 0.04 4.7 38.3 49
5 6 13.5 0.02 4.7 39.02 51
4 7 12 0.02 4.5 37.24 46
7 8 12 0.04 4.6 37.92 49
1 9 12 0 4.5 38 35
Table 4: Results of regression analysis for responses
Responses Value F-value p-value
pH














was studied, and it was observed that there was no interaction 
between pure drug and drug-excipients mixture which was depicted 
in Fig. 1.
Differential scanning calorimetry
It was evident that DSC of physical mixture and pure drug showed 
endothermic peak corresponding to fluconazole around 145.85°C as 
depicted in Fig. 2. Hence, from the results, it was inferred that there was 
no interaction between the pure drug and physical mixture.
Formulation and optimization of temperature induced in situ gel 
loaded with fluconazole
From the results depicted in Table 3, it was evident that variables 
that have chosen have a strong impact on responses. On application 
of factorial design, the following regression equations were obtained. 
In which negative values indicate negative effect of a specific variable 
on the response factor and positive value indicates positive effect of a 
specific variable.
pH = +3.41667+0.088889 Pluronic F-127+2.5 Carbapol-934
Viscosity = +14.35944+1.89333Pluronic F-127+2.75000Carbapol-934
Gelation Time = -363.52778+58.83333 Pluronic 
F-127+2579.16667Carbapol-934
ANOVA studies suggested that all the models were significant for the 
responses shown which were depicted in Table 4, and polynomial 
regression results were expressed using three-dimensional graphs and 
contour plots which were depicted in Figs. 3a-c and 4a-c.
Optimization
To design the optimized in situ gel, required response values were 
depicted in Table 5. The combination which resulted in achieving the 
required specifications was done using the design expert software. To 
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Table 5: Optimization of temperature-induced in situ gel loaded with fluconazole
Value Pluronic F-127 (ml) Carbapol-934 (mg) Response pH Response viscosity (cps) Response gelation time (s)
Predicted 14.932 0.03 4.9 43.3 35
Actual 14.82 0.03 4.9 43.1 36
% error 0.112 - - 0.2 1
Table 6: Results of evaluated physiochemical parameters
Tests S1 S2 S3 S4 S5 S6 S7 S8 S9
Visual appearance Clear Clear Clear Clear Clear Clear Clear Clear Clear
pH 4.7 4.8 4.9 4.6 4.7 4.7 4.5 4.6 4.5
Viscosity (Cps) 44.8 42.1 43.3 39.09 38.3 39.02 37.24 37.92 38
Table 7: Results of prepared formulations for gelation 
temperature and time










*Mean±SD, n=3. SD: Standard deviation
Evaluation of formulated in situ gels
Clarity
The visual appearance of formulated gel (S1-S11) was found to be clear 
when observed against a white and black background, and the results 
were depicted in Table 6.
pH
The optimal pH range for any in situ gel is 4.7–4.9 and the formulated 
gels loaded with Fluconazole had shown within the range of 4.6–4.9 as 
depicted in Table 6. From the results obtained, it can be inferred that pH 
of the formulated in situ gels was within the range.
Viscosity
The viscosities of the formulated gels were found to be within the 
range of 38–45 cps which was depicted in Table 6. From the results, it 
can be inferred that as the concentration of Pluronic F-127 increases 
there was an increase in viscosity, due to decreased distance between 
micelles which, in turn, lead to increased interactions between them 
and resulting in developing viscous gels.
Gelation temperature and time
As depicted in Table 7, all the formulated in situ gels had shown gel-like 
viscosity within a temperature range of 22–59°C and the formulations 
showed gelation within 35–51 s depending on the concentrations of 
Pluronic F-127 and Carbopol-934. From the results obtained, it was 
inferred that S1, S3, and S9 had shown gelation at body temperature, 
whereas formulation S3 and S9, i.e. 35 s had shown gelation faster when 
compared with other formulations and every addition of 0.1% w/w 
CP 934 into the formulations leaded to 5°C increase in gelation 
temperature.
Mucoadhesive force
Results obtained from mucoadhesive force study suggested that adhesive 
property of Pluronic F-127 increases with increase in concentration 
of Carbopol-934. Formulation S3 had shown more strength 
(5210.32 dynes/cm2) when compared with S1 (4650.29dynes/cm2) 
and S9 (5123dynes/cm2). From the results, it can be inferred that 
more the mucoadhesive force, more it can prevent fallout of the gelled 
solution from mucosa.
In vitro diffusion studies
The formulated gels S1, S3, and S9 retarded drug release from in situ gel 
for 10–12 h as depicted in Fig. 5. Results suggested that S3 formulation 
has sustained the release of drug up to 12 h, while formulations S1 
and S9 had completely diffused the drug within 8 h. From the results 
obtained, it can be inferred that as the concentration of polymers 
increased, release of drug from in situ gel was retarded.
CONCLUSION
Thermoreversible in situ gels loaded with fluconazole were formulated 
and optimized successfully by cold technique by employing DoE software. 
FTIR and DSC studies suggested that there was no chemical interaction 
present between the pure drug and physical mixture. Among different 
formulations S1, S3, and S9 have shown gelation at body temperature. 
From the data obtained from in vitro studies and mucoadhesive study 
as S3 was considered as optimum formulation as it sustained the 
release of the drug up to 12 h and shown a mucoadhesive strength of 
5210.32 dynes/cm2, while other formulations diffused the drug completely 
by 6–8 h and shown a mucoadhesive strength of 4650.29 dynes/cm2 and 
5123dynes/cm2. From the results, it can be concluded that formulated 
in situ gel can be used as an alternative approach to treat candidiasis.
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